Article information
El síndrome de Stevens-Johnson es una enfermedad mucocutánea sistémica, asociada frecuentemente a medicamentos. Se presenta el caso de un paciente de 35 años de edad con diagnóstico de lupus eritematoso sistémico en tratamiento con prednisona, que desarrolló un síndrome de Stevens-Johnson que se trató con pulsos de metilprednisolona.
Palabras clave:
Síndrome de Stevens Jonson
Lupus eritematoso sistémico
Prednisona
Stevens-Johnson syndrome is a systemic, mucocutaneous disease, frequently related to drugs. We present the case of a 35-year old patient with a diagnosis of systemic lupus erythematous treated with prednisone who developed a Stevens-Johnson syndrome and was treated with methylprednisolone.
Key words:
Stevens-Johnson syndrome
Systemic lupus erythematosus
Prednisone
Full text is only aviable in PDF
Bibliografía
[1.]
T.P. Habif.
Clinical Dermatology.
Mosby Year Bock, (1996),
[2.]
T.M. Stampien, R.A. Schwartz.
Erythema multiforme.
Am Fam Physician, 46 (1992), pp. 1171-1176
[3.]
H.C. Ting, B.A. Adam.
Stevens-Johnson syndrome. A review of 34 cases.
Int J Dermatol, 24 (1985), pp. 587-591
[4.]
D.B. Lew, G.C. Higgins, R.B. Skinner, M.D. Snider, L.K. Myers.
Adverse reaction to prednisone in a patient with systemic lupus erythematosus.
Pediatr Dermatol, 16 (1999), pp. 146-150
[6.]
R. Patterson, L.C. Grammer, P.A. Greenberger, I.D. Lawrence, C.R. Zeiss, P.F. Detjen, et al.
Stevens Johnson syndrome: effectiveness of corticosteroids in the management and recurrent SJS.
Allergy Proc, 13 (1992), pp. 89-95
[7.]
S. Cheriyan, R. Patterson, P.A. Greenberger, L.C. Grammer, J. Latall.
The outcome of Stevens-Johnson syndrome treated with corticosteroids.
Allergy Proc, 16 (1995), pp. 151-155
[8.]
A.E. Martínez, D.J. Atherton.
High dose systemic corticosteroids can arrest recurrences of severe mucocutaneous erythema multiforme.
Pediatr Dermatol, 17 (2000), pp. 87-90
[9.]
P.S. Kim, I.W. Goldfarb, J.C. Gaisford, et al.
Stevens-Johnson syndrome and toxic epidermal necrolysis: a pathophysiologic review with recommendations for a treatment protocol.
J Burn Care Rehabil, 4 (1983), pp. 91-100
[10.]
A.Y. Hynes, C. Kafkala, Y.J. Daoud, C.S. Foster.
Controversy in the use of high-dose systemic steroids in the acute care of patients with stevens-johnson syndrome.
Int Ophthalmol Clin, 45 (2005), pp. 25-48
[11.]
S.S. Samimi, E. Siegfried, N.H. Nielsen, B.M. Hultberg.
Stevens Johnson Syndrome developing in a girl with Systemic Lupus Erythematosus on high dose corticosteroid therapy.
Pediatr Dermatol, 19 (2002), pp. 52-55
[12.]
W.L. Weston.
Blistering diseases in children. How to recognize and treat the most common.
Postgrad Med, 80 (1986), pp. 241-249
Copyright © 2006. Elsevier España S.L. Barcelona
